Literature DB >> 6339810

Complement localization in ischemic baboon myocardium.

L M McManus, W P Kolb, M H Crawford, R A O'Rourke, F L Grover, R N Pinckard.   

Abstract

Complement localization was examined by direct immunoperoxidase procedures on frozen sections of baboon myocardium obtained 24 hours after ligation of the left anterior descending coronary artery. There was extensive localization of C3, C4, and C5 in most infarcted myocardial fibers; however, in these infarcted areas of myocardium, complement components were not found in myocytes immediately adjacent to either the endocardium or epicardium. Although C3, C4, and C5 were all present within the same myocardial fibers as assessed in adjacent serial sections, the light microscopic distribution of these components was dissimilar, i.e., C3 and C5 were present in both a granular and a diffuse pattern within myocytes, whereas C4 was always localized in a diffuse pattern. Complement components C3 and C5, but not C4, were also localized in the walls of small muscular arteries in infarcted myocardium. No complement was observed in myocardial fibers or blood vessels in normal baboon myocardium. Electron microscopic evaluation of C3 localization within infarcted myocardium indicated that C3 was associated with contractile elements of myocytes, as well as with membranes of myocyte nuclei, mitochondria, and sarcoplasmic reticulum. Within vascular smooth muscular cells, C3 was associated with myofilaments and mitochondrial membranes. Thus, the results of this study provide new information regarding the cellular and subcellular distribution of complement components in infarcted baboon myocardium. If this localization of C3, C4, and C5 is a result of their in situ activation within the ischemic myocardium, a variety of complement-derived phlogistic products would be expected to have been produced and to have effected, in part, the subsequent inflammatory response.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6339810

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  9 in total

1.  Membrane attack complex of complement and 20 kDa homologous restriction factor (CD59) in myocardial infarction.

Authors:  T Tada; H Okada; N Okada; H Tateyama; H Suzuki; Y Takahashi; T Eimoto
Journal:  Virchows Arch       Date:  1997-04       Impact factor: 4.064

2.  Capillary leakage in inflammation. A study by vascular labeling.

Authors:  I Joris; H F Cuénoud; G V Doern; J M Underwood; G Majno
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

3.  Decay-accelerating factor is expressed on vascular smooth muscle cells in human atherosclerotic lesions.

Authors:  P S Seifert; G K Hansson
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

4.  Association of the complement factor H Y402H polymorphism with cardiovascular disease is dependent upon hypertension status: The ARIC study.

Authors:  Kelly A Volcik; Christie M Ballantyne; Michael C Braun; Josef Coresh; Thomas H Mosley; Eric Boerwinkle
Journal:  Am J Hypertens       Date:  2008-02-21       Impact factor: 2.689

5.  Relation of early mononuclear and polymorphonuclear cell infiltration to late scar thickness after experimentally induced myocardial infarction in the rat.

Authors:  C S Roberts; D Maclean; P Maroko; R A Kloner
Journal:  Basic Res Cardiol       Date:  1985 Mar-Apr       Impact factor: 17.165

6.  Antibody-independent activation of the complement system by mitochondria is mediated by cardiolipin.

Authors:  M C Peitsch; J Tschopp; A Kress; H Isliker
Journal:  Biochem J       Date:  1988-01-15       Impact factor: 3.857

7.  Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit. Evidence for a role for C5a and interleukin-8.

Authors:  C L Ivey; F M Williams; P D Collins; P J Jose; T J Williams
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

8.  Xanthine oxidase, but not neutrophils, contributes to activation of cardiac sympathetic afferents during myocardial ischaemia in cats.

Authors:  Stephanie C Tjen-A-Looi; Liang-Wu Fu; John C Longhurst
Journal:  J Physiol       Date:  2002-08-15       Impact factor: 5.182

9.  Anticomplement therapy.

Authors:  Prathit A Kulkarni; Vahid Afshar-Kharghan
Journal:  Biologics       Date:  2008-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.